Literature DB >> 10640270

Role of the rasGAP-associated docking protein p62(dok) in negative regulation of B cell receptor-mediated signaling.

Y Yamanashi1, T Tamura, T Kanamori, H Yamane, H Nariuchi, T Yamamoto, D Baltimore.   

Abstract

Antigenic stimulation of the B-cell receptor (BCR) is a central event in the immune response. In contrast, antigen bound to IgG negatively regulates signals from the BCR by cross-linking it to the inhibitory receptor FcgammaRIIB. Here we show that upon cross-linking of BCR or BCR with FcgammaRIIB, the rasGAP-associated protein p62(dok) is prominently tyrosine phosphorylated in a Lyn-dependent manner. Inactivation of the dok gene by homologous recombination has shown that upon BCR cross-linking, p62(dok) suppresses MAP kinase and is indispensable for FcgammaRIIB-mediated negative regulation of cell proliferation. We propose that p62(dok), a downstream target of many PTKs, plays a negative role in various signaling situations.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10640270      PMCID: PMC316343     

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  33 in total

1.  T cell activation through TCR/-CD3 complex. IL-2 production of T cell clones stimulated with anti-CD3 without cross-linkage.

Authors:  T Tamura; H Nariuchi
Journal:  J Immunol       Date:  1992-04-15       Impact factor: 5.422

2.  Phosphorylation of GAP and GAP-associated proteins by transforming and mitogenic tyrosine kinases.

Authors:  C Ellis; M Moran; F McCormick; T Pawson
Journal:  Nature       Date:  1990-01-25       Impact factor: 49.962

3.  Mechanisms of T cell contact-dependent B cell activation.

Authors:  T Kato; T Kokuho; T Tamura; H Nariuchi
Journal:  J Immunol       Date:  1994-03-01       Impact factor: 5.422

4.  Role of the inositol phosphatase SHIP in B cell receptor-induced Ca2+ oscillatory response.

Authors:  H Okada; S Bolland; A Hashimoto; M Kurosaki; Y Kabuyama; M Iino; J V Ravetch; T Kurosaki
Journal:  J Immunol       Date:  1998-11-15       Impact factor: 5.422

5.  Recruitment of Dok-R to the EGF receptor through its PTB domain is required for attenuation of Erk MAP kinase activation.

Authors:  N Jones; D J Dumont
Journal:  Curr Biol       Date:  1999-09-23       Impact factor: 10.834

6.  Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene.

Authors:  V L Tybulewicz; C E Crawford; P K Jackson; R T Bronson; R C Mulligan
Journal:  Cell       Date:  1991-06-28       Impact factor: 41.582

7.  Independent SH2-binding sites mediate interaction of Dok-related protein with RasGTPase-activating protein and Nck.

Authors:  P Lock; F Casagranda; A R Dunn
Journal:  J Biol Chem       Date:  1999-08-06       Impact factor: 5.157

8.  Interactions of p62(dok) with p210(bcr-abl) and Bcr-Abl-associated proteins.

Authors:  A Bhat; K J Johnson; T Oda; A S Corbin; B J Druker
Journal:  J Biol Chem       Date:  1998-11-27       Impact factor: 5.157

9.  Tyrosine phosphorylation of p62(Dok) induced by cell adhesion and insulin: possible role in cell migration.

Authors:  T Noguchi; T Matozaki; K Inagaki; M Tsuda; K Fukunaga; Y Kitamura; T Kitamura; K Shii; Y Yamanashi; M Kasuga
Journal:  EMBO J       Date:  1999-04-01       Impact factor: 11.598

10.  Targets of B lymphocyte antigen receptor signal transduction include the p21ras GTPase-activating protein (GAP) and two GAP-associated proteins.

Authors:  M R Gold; M T Crowley; G A Martin; F McCormick; A L DeFranco
Journal:  J Immunol       Date:  1993-01-15       Impact factor: 5.422

View more
  44 in total

Review 1.  ITAMs versus ITIMs: striking a balance during cell regulation.

Authors:  Daniel D Billadeau; Paul J Leibson
Journal:  J Clin Invest       Date:  2002-01       Impact factor: 14.808

2.  Inhibition of the motility and growth of B16F10 mouse melanoma cells by dominant negative mutants of Dok-1.

Authors:  T Hosooka; T Noguchi; H Nagai; T Horikawa; T Matozaki; M Ichihashi; M Kasuga
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

Review 3.  Ligand-dependent and -independent processes in B-cell-receptor-mediated signaling.

Authors:  E M Fuentes-Pananá; J G Monroe
Journal:  Springer Semin Immunopathol       Date:  2001-12

4.  Downregulation of the Ras-mitogen-activated protein kinase pathway by the EphB2 receptor tyrosine kinase is required for ephrin-induced neurite retraction.

Authors:  S Elowe; S J Holland; S Kulkarni; T Pawson
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

Review 5.  Molecular underpinning of B-cell anergy.

Authors:  Yuval Yarkoni; Andrew Getahun; John C Cambier
Journal:  Immunol Rev       Date:  2010-09       Impact factor: 12.988

6.  Lyn kinase promotes erythroblast expansion and late-stage development.

Authors:  Vinit G Karur; Clifford A Lowell; Peter Besmer; Valter Agosti; Don M Wojchowski
Journal:  Blood       Date:  2006-05-16       Impact factor: 22.113

7.  Dok-1 independently attenuates Ras/mitogen-activated protein kinase and Src/c-myc pathways to inhibit platelet-derived growth factor-induced mitogenesis.

Authors:  Mingming Zhao; Justyna A Janas; Masaru Niki; Pier Paolo Pandolfi; Linda Van Aelst
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

Review 8.  Fc receptors and their role in immune regulation and autoimmunity.

Authors:  Toshiyuki Takai
Journal:  J Clin Immunol       Date:  2005-01       Impact factor: 8.317

9.  IkappaB kinase beta phosphorylates Dok1 serines in response to TNF, IL-1, or gamma radiation.

Authors:  Sanghoon Lee; Charlotte Andrieu; Frédéric Saltel; Olivier Destaing; Jessie Auclair; Véronique Pouchkine; Jocelyne Michelon; Bruno Salaun; Ryuji Kobayashi; Pierre Jurdic; Elliott D Kieff; Bakary S Sylla
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-01       Impact factor: 11.205

10.  The inhibitory potential of Fc receptor homolog 4 on memory B cells.

Authors:  Gotz R A Ehrhardt; Randall S Davis; Joyce T Hsu; Chuen-Miin Leu; Annette Ehrhardt; Max D Cooper
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-03       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.